Does an off-label two-dose RotaTeq vaccine schedule translate into a higher incidence of rotavirus hospital admissions compared to the approved three-dose RotaTeq schedule? A Canadian immunization research network study.
Saved in:
| Title: | Does an off-label two-dose RotaTeq vaccine schedule translate into a higher incidence of rotavirus hospital admissions compared to the approved three-dose RotaTeq schedule? A Canadian immunization research network study. |
|---|---|
| Authors: | Fortin É; Département de médecine sociale et préventive, Faculté de Médicine, Université Laval, Quebec, Quebec, Canada; Biological Risks Departement, Institut national de santé publique du Québec (INSPQ), Quebec, Quebec, Canada; Department of Microbiology, Infectious Diseases, and Immunology, Faculty of Medicine, University of Montreal, Quebec, Canada., Miron É; Département de médecine sociale et préventive, Faculté de Médicine, Université Laval, Quebec, Quebec, Canada., Grewal R; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada; Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, Ontario, Canada., Wilson SE; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada; Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, Ontario, Canada; Public Health Ontario, Toronto, Ontario, Canada; Institute for Clinical Evaluative Sciences (ICES), Toronto, Ontario, Canada., Janjua NZ; UBC Centre for Disease Control, University of British Columbia, Vancouver, BC, Canada; School of Population and Public Health, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada., Quach C; Departments of Microbiology, Infectious Diseases, and Immunology & of Pediatrics, Université de Montréal and Clinical Department of Laboratory Medicine, CHU Sainte-Justine, Montreal, Quebec, Canada., Sadarangani M; Vaccine Evaluation Center, BC Children's Hospital Research Institute, University of British Columbia, Vancouver, BC, Canada; Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada., Kiely M; Département de médecine sociale et préventive, Faculté de Médicine, Université Laval, Quebec, Quebec, Canada; CHU de Québec Research Centre - Université Laval, Quebec, Quebec, Canada., Naveed Z; UBC Centre for Disease Control, University of British Columbia, Vancouver, BC, Canada., Naus M; School of Population and Public Health, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada., MacDonald SE; Faculty of Nursing, University of Alberta, Edmonton, Alberta, Canada., Swayze S; Institute for Clinical Evaluative Sciences (ICES), Toronto, Ontario, Canada., Brousseau N; Département de médecine sociale et préventive, Faculté de Médicine, Université Laval, Quebec, Quebec, Canada; Biological Risks Departement, Institut national de santé publique du Québec (INSPQ), Quebec, Quebec, Canada; CHU de Québec Research Centre - Université Laval, Quebec, Quebec, Canada. Electronic address: nicholas.brousseau@inspq.qc.ca. |
| Source: | Vaccine [Vaccine] 2026 Jun 11; Vol. 83, pp. 128628. Date of Electronic Publication: 2026 May 02. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42070371 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Does an off-label two-dose RotaTeq vaccine schedule translate into a higher incidence of rotavirus hospital admissions compared to the approved three-dose RotaTeq schedule? A Canadian immunization research network study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Fortin+É%22">Fortin É</searchLink>; Département de médecine sociale et préventive, Faculté de Médicine, Université Laval, Quebec, Quebec, Canada; Biological Risks Departement, Institut national de santé publique du Québec (INSPQ), Quebec, Quebec, Canada; Department of Microbiology, Infectious Diseases, and Immunology, Faculty of Medicine, University of Montreal, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Miron+É%22">Miron É</searchLink>; Département de médecine sociale et préventive, Faculté de Médicine, Université Laval, Quebec, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Grewal+R%22">Grewal R</searchLink>; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada; Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Wilson+SE%22">Wilson SE</searchLink>; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada; Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, Ontario, Canada; Public Health Ontario, Toronto, Ontario, Canada; Institute for Clinical Evaluative Sciences (ICES), Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Janjua+NZ%22">Janjua NZ</searchLink>; UBC Centre for Disease Control, University of British Columbia, Vancouver, BC, Canada; School of Population and Public Health, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Quach+C%22">Quach C</searchLink>; Departments of Microbiology, Infectious Diseases, and Immunology & of Pediatrics, Université de Montréal and Clinical Department of Laboratory Medicine, CHU Sainte-Justine, Montreal, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Sadarangani+M%22">Sadarangani M</searchLink>; Vaccine Evaluation Center, BC Children's Hospital Research Institute, University of British Columbia, Vancouver, BC, Canada; Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Kiely+M%22">Kiely M</searchLink>; Département de médecine sociale et préventive, Faculté de Médicine, Université Laval, Quebec, Quebec, Canada; CHU de Québec Research Centre - Université Laval, Quebec, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Naveed+Z%22">Naveed Z</searchLink>; UBC Centre for Disease Control, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Naus+M%22">Naus M</searchLink>; School of Population and Public Health, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22MacDonald+SE%22">MacDonald SE</searchLink>; Faculty of Nursing, University of Alberta, Edmonton, Alberta, Canada.<br /><searchLink fieldCode="AU" term="%22Swayze+S%22">Swayze S</searchLink>; Institute for Clinical Evaluative Sciences (ICES), Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Brousseau+N%22">Brousseau N</searchLink>; Département de médecine sociale et préventive, Faculté de Médicine, Université Laval, Quebec, Quebec, Canada; Biological Risks Departement, Institut national de santé publique du Québec (INSPQ), Quebec, Quebec, Canada; CHU de Québec Research Centre - Université Laval, Quebec, Quebec, Canada. Electronic address: nicholas.brousseau@inspq.qc.ca. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228406899%22">Vaccine</searchLink> [Vaccine] 2026 Jun 11; Vol. 83, pp. 128628. <i>Date of Electronic Publication: </i>2026 May 02. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8406899 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-2518 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220264410X%22">0264410X </searchLink><i>NLM ISO Abbreviation: </i>Vaccine <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42070371 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.vaccine.2026.128628 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 128628 Titles: – TitleFull: Does an off-label two-dose RotaTeq vaccine schedule translate into a higher incidence of rotavirus hospital admissions compared to the approved three-dose RotaTeq schedule? A Canadian immunization research network study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Fortin É – PersonEntity: Name: NameFull: Miron É – PersonEntity: Name: NameFull: Grewal R – PersonEntity: Name: NameFull: Wilson SE – PersonEntity: Name: NameFull: Janjua NZ – PersonEntity: Name: NameFull: Quach C – PersonEntity: Name: NameFull: Sadarangani M – PersonEntity: Name: NameFull: Kiely M – PersonEntity: Name: NameFull: Naveed Z – PersonEntity: Name: NameFull: Naus M – PersonEntity: Name: NameFull: MacDonald SE – PersonEntity: Name: NameFull: Swayze S – PersonEntity: Name: NameFull: Brousseau N IsPartOfRelationships: – BibEntity: Dates: – D: 11 M: 06 Text: 2026 Jun 11 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1873-2518 Numbering: – Type: volume Value: 83 Titles: – TitleFull: Vaccine Type: main |
| ResultId | 1 |
